Follow the 科兴制药 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 科兴制药 has published 7 public disclosures. Market capitalisation: €4.8bn. The latest transaction was reported on 20 August 2026 (Sale). Among the most active insiders: 邓学勤. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
科兴制药 is a company specializing in the health and pharmaceutical sector, listed on the XSHG market. It focuses on the development and production of vaccines and biopharmaceutical products.